3880 — Medtide Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual income statement for Medtide, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Revenue
Total Revenue	351	337	442
Cost of Revenue
Gross Profit	201	180	250
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	215	229	279
Operating Profit	136	108	163
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	67.6	62	78.4
Provision for Income Taxes
Net Income After Taxes	54	48.9	59.2
Net Income Before Extraordinary Items
Net Income	54	48.9	59.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	54	48.9	59.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.385	0.349	0.556